Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Device Removal | 5 | 2023 | 643 | 0.990 |
Why?
|
Angiography | 3 | 2020 | 1597 | 0.740 |
Why?
|
Vena Cava Filters | 3 | 2021 | 270 | 0.640 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 8 | 2008 | 304 | 0.590 |
Why?
|
Pulmonary Artery | 3 | 2024 | 1946 | 0.550 |
Why?
|
Foreign Bodies | 1 | 2019 | 403 | 0.480 |
Why?
|
Yttrium Radioisotopes | 1 | 2015 | 114 | 0.460 |
Why?
|
Embolization, Therapeutic | 4 | 2024 | 1401 | 0.460 |
Why?
|
Male Urogenital Diseases | 1 | 2014 | 48 | 0.450 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1429 | 0.440 |
Why?
|
Pulmonary Embolism | 5 | 2021 | 2599 | 0.440 |
Why?
|
Aortic Aneurysm, Abdominal | 5 | 2023 | 1250 | 0.430 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 347 | 0.420 |
Why?
|
Ultrasonography, Interventional | 2 | 2023 | 1524 | 0.390 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1131 | 0.380 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2009 | 627 | 0.360 |
Why?
|
Liver Neoplasms | 5 | 2020 | 4363 | 0.330 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 2024 | 141 | 0.330 |
Why?
|
Pelvis | 1 | 2014 | 736 | 0.330 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1304 | 0.310 |
Why?
|
Arteriovenous Malformations | 2 | 2024 | 396 | 0.310 |
Why?
|
Radiology | 4 | 2020 | 2104 | 0.300 |
Why?
|
Chromomycin A3 | 1 | 2007 | 3 | 0.290 |
Why?
|
Societies, Medical | 10 | 2023 | 3968 | 0.290 |
Why?
|
Brachytherapy | 1 | 2015 | 1220 | 0.290 |
Why?
|
Vascular Diseases | 2 | 2019 | 1162 | 0.280 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2020 | 2334 | 0.270 |
Why?
|
Endovascular Procedures | 2 | 2019 | 2217 | 0.260 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2009 | 1143 | 0.250 |
Why?
|
Pulmonary Veins | 2 | 2024 | 758 | 0.250 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 1805 | 0.240 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2176 | 0.230 |
Why?
|
Splenic Artery | 1 | 2024 | 58 | 0.220 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2007 | 681 | 0.220 |
Why?
|
Radiology, Interventional | 2 | 2020 | 483 | 0.220 |
Why?
|
Image Enhancement | 1 | 2014 | 2880 | 0.220 |
Why?
|
Blood Vessel Prosthesis | 2 | 2021 | 957 | 0.210 |
Why?
|
Cytotoxins | 1 | 2004 | 154 | 0.210 |
Why?
|
Carcinoma, Renal Cell | 5 | 2011 | 3187 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.210 |
Why?
|
Quality Improvement | 2 | 2015 | 3857 | 0.210 |
Why?
|
Vena Cava, Inferior | 2 | 2016 | 463 | 0.200 |
Why?
|
Tumor Suppressor Proteins | 4 | 2007 | 2810 | 0.200 |
Why?
|
Cell Hypoxia | 4 | 2007 | 662 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 998 | 0.190 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2004 | 221 | 0.190 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.190 |
Why?
|
Diagnostic Imaging | 6 | 2024 | 3533 | 0.190 |
Why?
|
Iodine | 1 | 2023 | 285 | 0.180 |
Why?
|
Neoplasms | 6 | 2024 | 22371 | 0.180 |
Why?
|
Aneurysm | 1 | 2024 | 343 | 0.180 |
Why?
|
Aneurysm, Infected | 1 | 2021 | 81 | 0.180 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.180 |
Why?
|
Arteriovenous Fistula | 1 | 2024 | 320 | 0.180 |
Why?
|
Catheters | 1 | 2023 | 427 | 0.180 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2023 | 208 | 0.170 |
Why?
|
Needles | 1 | 2023 | 461 | 0.170 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2020 | 189 | 0.170 |
Why?
|
Kidney Neoplasms | 4 | 2011 | 4282 | 0.160 |
Why?
|
Alloys | 1 | 2019 | 111 | 0.160 |
Why?
|
Microwaves | 1 | 2020 | 184 | 0.160 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1321 | 0.160 |
Why?
|
Vasculitis | 2 | 2021 | 525 | 0.150 |
Why?
|
Oxygen | 7 | 2007 | 4270 | 0.150 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2020 | 97 | 0.150 |
Why?
|
Cell Death | 1 | 2004 | 1680 | 0.150 |
Why?
|
Polytetrafluoroethylene | 1 | 2019 | 245 | 0.150 |
Why?
|
Evidence-Based Medicine | 8 | 2023 | 3706 | 0.150 |
Why?
|
Hemophilia A | 1 | 2021 | 359 | 0.150 |
Why?
|
Thiazoles | 3 | 2010 | 1542 | 0.140 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 311 | 0.140 |
Why?
|
Iliac Artery | 1 | 2018 | 344 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2010 | 2237 | 0.140 |
Why?
|
Quality Control | 1 | 2019 | 836 | 0.140 |
Why?
|
Autophagy | 3 | 2010 | 1351 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 409 | 0.130 |
Why?
|
Drug Carriers | 1 | 2020 | 710 | 0.130 |
Why?
|
Energy Metabolism | 1 | 2007 | 2907 | 0.130 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 128 | 0.130 |
Why?
|
Ileal Diseases | 1 | 2016 | 70 | 0.130 |
Why?
|
Humans | 63 | 2024 | 768171 | 0.130 |
Why?
|
Portal Vein | 2 | 2015 | 435 | 0.130 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2016 | 93 | 0.130 |
Why?
|
Uterine Artery Embolization | 1 | 2016 | 62 | 0.130 |
Why?
|
Prosthesis-Related Infections | 1 | 2021 | 497 | 0.130 |
Why?
|
Waiting Lists | 1 | 2020 | 779 | 0.120 |
Why?
|
Uterine Diseases | 1 | 2016 | 108 | 0.120 |
Why?
|
Urinary Fistula | 1 | 2015 | 44 | 0.120 |
Why?
|
Intestinal Fistula | 1 | 2016 | 146 | 0.120 |
Why?
|
Peripheral Vascular Diseases | 1 | 2018 | 489 | 0.120 |
Why?
|
Workflow | 1 | 2020 | 860 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2021 | 742 | 0.120 |
Why?
|
Vascular Fistula | 1 | 2015 | 50 | 0.120 |
Why?
|
Fluoroscopy | 1 | 2019 | 947 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 2846 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 939 | 0.110 |
Why?
|
Bacteremia | 1 | 2021 | 985 | 0.110 |
Why?
|
Extremities | 1 | 2019 | 870 | 0.110 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 96 | 0.110 |
Why?
|
Hepatic Encephalopathy | 1 | 2015 | 144 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 1 | 2018 | 745 | 0.110 |
Why?
|
Vascular Malformations | 1 | 2019 | 469 | 0.110 |
Why?
|
Docosahexaenoic Acids | 1 | 2020 | 914 | 0.110 |
Why?
|
Practice Management, Medical | 1 | 2015 | 191 | 0.110 |
Why?
|
Mitochondria | 1 | 2007 | 3683 | 0.110 |
Why?
|
Sialoglycoproteins | 2 | 2005 | 320 | 0.110 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1430 | 0.110 |
Why?
|
Triage | 1 | 2020 | 997 | 0.110 |
Why?
|
Hypertension, Portal | 1 | 2015 | 230 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2018 | 905 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 2016 | 433 | 0.100 |
Why?
|
Transcription Factors | 4 | 2005 | 12171 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1398 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2016 | 594 | 0.100 |
Why?
|
Leiomyoma | 1 | 2016 | 644 | 0.090 |
Why?
|
Critical Pathways | 1 | 2015 | 476 | 0.090 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 186 | 0.090 |
Why?
|
Aorta | 1 | 2018 | 2045 | 0.090 |
Why?
|
United States | 13 | 2023 | 73039 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13668 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1217 | 0.080 |
Why?
|
Osteopontin | 3 | 2006 | 311 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2008 | 193 | 0.080 |
Why?
|
Luminescent Measurements | 2 | 2008 | 342 | 0.080 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2009 | 81 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2019 | 1279 | 0.080 |
Why?
|
Stents | 2 | 2024 | 3197 | 0.080 |
Why?
|
von Hippel-Lindau Disease | 1 | 2010 | 154 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.080 |
Why?
|
Luciferases, Firefly | 1 | 2008 | 37 | 0.080 |
Why?
|
Pyridines | 3 | 2010 | 2894 | 0.080 |
Why?
|
Proline | 3 | 2008 | 455 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2001 | 2956 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1882 | 0.070 |
Why?
|
Quinones | 2 | 1998 | 79 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2024 | 65379 | 0.070 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 17142 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9617 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1424 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2780 | 0.070 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 13013 | 0.070 |
Why?
|
Neovascularization, Pathologic | 2 | 2009 | 2631 | 0.070 |
Why?
|
Contrast Media | 4 | 2023 | 5330 | 0.070 |
Why?
|
Tumor Cells, Cultured | 6 | 2004 | 6124 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2019 | 2517 | 0.060 |
Why?
|
Antineoplastic Agents | 5 | 2011 | 13677 | 0.060 |
Why?
|
Male | 23 | 2024 | 364731 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2004 | 1901 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11244 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1702 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2015 | 1459 | 0.060 |
Why?
|
Female | 19 | 2024 | 397187 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 719 | 0.060 |
Why?
|
Phlebography | 2 | 2016 | 326 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 9016 | 0.060 |
Why?
|
Aniline Compounds | 1 | 2010 | 1094 | 0.060 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2004 | 37 | 0.060 |
Why?
|
Neoplasms, Experimental | 1 | 2009 | 1230 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2024 | 81760 | 0.060 |
Why?
|
Adult | 10 | 2024 | 223646 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2006 | 444 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2007 | 1524 | 0.050 |
Why?
|
Polyurethanes | 1 | 2024 | 110 | 0.050 |
Why?
|
Middle Aged | 14 | 2024 | 223487 | 0.050 |
Why?
|
Electric Power Supplies | 1 | 2023 | 96 | 0.050 |
Why?
|
Genes, ras | 1 | 2005 | 663 | 0.050 |
Why?
|
Animals | 18 | 2023 | 169285 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2024 | 59626 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Head and Neck Neoplasms | 3 | 2006 | 2931 | 0.050 |
Why?
|
Blotting, Western | 2 | 2007 | 5028 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 317 | 0.050 |
Why?
|
Thrombin Time | 1 | 2021 | 7 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2414 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2008 | 8648 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2006 | 4058 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 20762 | 0.050 |
Why?
|
Infusions, Intra-Arterial | 1 | 2020 | 220 | 0.040 |
Why?
|
Genes, Fungal | 1 | 2002 | 440 | 0.040 |
Why?
|
Hydroxylation | 3 | 2005 | 139 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2024 | 770 | 0.040 |
Why?
|
Time Factors | 6 | 2024 | 40220 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11101 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4858 | 0.040 |
Why?
|
Apoptosis | 4 | 2011 | 9527 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 349 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1657 | 0.040 |
Why?
|
Aged | 9 | 2024 | 171502 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2016 | 2125 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 1367 | 0.040 |
Why?
|
Young Adult | 4 | 2024 | 60066 | 0.040 |
Why?
|
Algorithms | 5 | 2023 | 14164 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 627 | 0.040 |
Why?
|
Cyclophilins | 1 | 1998 | 47 | 0.040 |
Why?
|
Arm | 1 | 2021 | 591 | 0.040 |
Why?
|
Models, Molecular | 2 | 2008 | 5402 | 0.040 |
Why?
|
Peptidylprolyl Isomerase | 1 | 1998 | 97 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2004 | 5804 | 0.040 |
Why?
|
Drainage | 1 | 2023 | 1183 | 0.040 |
Why?
|
Photons | 1 | 2021 | 594 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2005 | 1767 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 644 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1263 | 0.040 |
Why?
|
Edema | 1 | 2021 | 765 | 0.030 |
Why?
|
Ultrasonography | 2 | 2023 | 6004 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4428 | 0.030 |
Why?
|
Palpation | 1 | 2017 | 166 | 0.030 |
Why?
|
Mice | 12 | 2009 | 82049 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 1998 | 3728 | 0.030 |
Why?
|
Sirolimus | 1 | 2004 | 1540 | 0.030 |
Why?
|
Recurrence | 3 | 2018 | 8509 | 0.030 |
Why?
|
Rectum | 1 | 2021 | 900 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2300 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 530 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 598 | 0.030 |
Why?
|
Enoxaparin | 1 | 2019 | 391 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6792 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4477 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3806 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2007 | 7609 | 0.030 |
Why?
|
Protons | 1 | 2021 | 1113 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1998 | 394 | 0.030 |
Why?
|
Lactulose | 1 | 2015 | 32 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2393 | 0.030 |
Why?
|
Texas | 1 | 2016 | 410 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1162 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 1998 | 423 | 0.030 |
Why?
|
Hepatic Veins | 1 | 2015 | 112 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1070 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 542 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2512 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2916 | 0.030 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 220 | 0.030 |
Why?
|
Trans-Activators | 1 | 2004 | 2857 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2015 | 331 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2661 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4064 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 664 | 0.030 |
Why?
|
Doxorubicin | 2 | 2017 | 2234 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2010 | 3056 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10763 | 0.030 |
Why?
|
Mice, SCID | 2 | 2009 | 2627 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5997 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1765 | 0.030 |
Why?
|
Research | 1 | 2002 | 1979 | 0.030 |
Why?
|
Liver | 2 | 2020 | 7578 | 0.030 |
Why?
|
Trauma Centers | 1 | 2019 | 951 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1443 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2021 | 1679 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2015 | 540 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6847 | 0.020 |
Why?
|
Dactinomycin | 2 | 2005 | 305 | 0.020 |
Why?
|
Risk Factors | 4 | 2024 | 74944 | 0.020 |
Why?
|
Vascular Patency | 1 | 2015 | 917 | 0.020 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 538 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1616 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15453 | 0.020 |
Why?
|
Mice, Nude | 2 | 2008 | 3623 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1208 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3522 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2016 | 583 | 0.020 |
Why?
|
Hysterectomy | 1 | 2016 | 863 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12543 | 0.020 |
Why?
|
Thrombosis | 1 | 2024 | 2957 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6986 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1967 | 0.020 |
Why?
|
Mutation | 5 | 2008 | 30237 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2785 | 0.020 |
Why?
|
Rats | 3 | 2020 | 23782 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9262 | 0.020 |
Why?
|
Program Development | 1 | 2015 | 1300 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6009 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2258 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1998 | 2451 | 0.020 |
Why?
|
Nanoparticles | 1 | 2020 | 1986 | 0.020 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2009 | 112 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2006 | 5442 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2007 | 3612 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12077 | 0.020 |
Why?
|
Luciferases, Renilla | 1 | 2007 | 22 | 0.020 |
Why?
|
Transfection | 2 | 2008 | 5756 | 0.020 |
Why?
|
Vacuoles | 1 | 2008 | 224 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 3814 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 466 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5315 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9540 | 0.020 |
Why?
|
Yeasts | 1 | 2008 | 279 | 0.020 |
Why?
|
Glycolysis | 1 | 2011 | 837 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1508 | 0.020 |
Why?
|
Genes, p53 | 2 | 2001 | 714 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2008 | 405 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3211 | 0.020 |
Why?
|
Benzoquinones | 2 | 1998 | 198 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 2007 | 286 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2507 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2008 | 406 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2007 | 575 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2006 | 91 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 705 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5099 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2008 | 284 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2016 | 2008 | 0.020 |
Why?
|
Lactams, Macrocyclic | 2 | 1998 | 319 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2018 | 15833 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 381 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2014 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2004 | 0.020 |
Why?
|
Reoperation | 1 | 2015 | 4329 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1998 | 4939 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6525 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2007 | 838 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14729 | 0.010 |
Why?
|
Lysosomes | 1 | 2010 | 938 | 0.010 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2006 | 1065 | 0.010 |
Why?
|
Response Elements | 1 | 2005 | 308 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2004 | 283 | 0.010 |
Why?
|
Molecular Structure | 1 | 2008 | 1884 | 0.010 |
Why?
|
3T3 Cells | 1 | 2005 | 1084 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2008 | 2486 | 0.010 |
Why?
|
Cell Line | 3 | 2005 | 15602 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2005 | 12801 | 0.010 |
Why?
|
RNA Stability | 1 | 2005 | 320 | 0.010 |
Why?
|
Transcriptional Activation | 2 | 2001 | 1750 | 0.010 |
Why?
|
Cullin Proteins | 1 | 2004 | 180 | 0.010 |
Why?
|
Anticoagulants | 1 | 2019 | 4850 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 30009 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1074 | 0.010 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 2002 | 23 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24318 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1951 | 0.010 |
Why?
|
Cobalt | 1 | 2002 | 148 | 0.010 |
Why?
|
Deferoxamine | 1 | 2002 | 155 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1505 | 0.010 |
Why?
|
Ligases | 1 | 2003 | 333 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3590 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36741 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2004 | 610 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1553 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9384 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4528 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 472 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 385 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 713 | 0.010 |
Why?
|
NF-kappa B | 1 | 2009 | 2494 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21538 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8747 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2006 | 1273 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3819 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3740 | 0.010 |
Why?
|
Glucose | 1 | 2011 | 4352 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 89169 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1931 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1648 | 0.010 |
Why?
|
Ubiquitin | 1 | 2004 | 843 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2885 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2001 | 362 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2005 | 14488 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3772 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5789 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2006 | 2914 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 109 | 0.010 |
Why?
|
Acetylation | 1 | 2001 | 1056 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 240 | 0.010 |
Why?
|
Intramolecular Oxidoreductases | 1 | 1998 | 105 | 0.010 |
Why?
|
Octoxynol | 1 | 1997 | 76 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6330 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2004 | 1110 | 0.010 |
Why?
|
Leupeptins | 1 | 1997 | 113 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1997 | 188 | 0.010 |
Why?
|
Cycloheximide | 1 | 1997 | 341 | 0.010 |
Why?
|
Gamma Rays | 1 | 1998 | 319 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 185 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1998 | 521 | 0.010 |
Why?
|
Detergents | 1 | 1997 | 235 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2459 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2202 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 11930 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2001 | 717 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2009 | 3589 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 3956 | 0.010 |
Why?
|
Half-Life | 1 | 1997 | 651 | 0.010 |
Why?
|
Growth Substances | 1 | 1998 | 760 | 0.010 |
Why?
|
Acetylcysteine | 1 | 1997 | 262 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2001 | 778 | 0.010 |
Why?
|
Ubiquitins | 1 | 1997 | 366 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54924 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3604 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3428 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2002 | 1758 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2005 | 3140 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2001 | 2732 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41753 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2892 | 0.010 |
Why?
|
Iron | 1 | 2002 | 1813 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19025 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 1998 | 762 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3348 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3445 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10478 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13422 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 6019 | 0.010 |
Why?
|
Cisplatin | 1 | 1998 | 1660 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2885 | 0.010 |
Why?
|
Lymphoma | 1 | 2001 | 1898 | 0.010 |
Why?
|
Fibroblasts | 1 | 2002 | 4178 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1997 | 1197 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17623 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2002 | 2682 | 0.010 |
Why?
|
DNA Damage | 1 | 2001 | 2469 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1997 | 1319 | 0.010 |
Why?
|
Protein Binding | 1 | 2002 | 9343 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8316 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3567 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 20225 | 0.000 |
Why?
|
Internet | 1 | 2001 | 3110 | 0.000 |
Why?
|
Software | 1 | 2001 | 4480 | 0.000 |
Why?
|
Gene Expression | 1 | 1998 | 7601 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9497 | 0.000 |
Why?
|
Signal Transduction | 1 | 2001 | 23648 | 0.000 |
Why?
|